Product Description
Retatrutide
Retatrutide, also known as LY3437943, is an investigational peptide being studied as a triple hormone-receptor agonist targeting the GIP, GLP-1 and glucagon receptors. It is currently being evaluated in Phase 3 clinical trials for obesity and related metabolic conditions.
Key Information
- High-quality research material
- Clearly labelled for identification and traceability
- Supplied in a securely sealed vial
- Suitable for controlled analytical and laboratory research
- Intended for use by qualified research professionals only
Storage
Store according to the instructions provided on the product label. Keep the vial securely sealed and protected from excessive heat, moisture and direct sunlight.
Important Notice
Retatrutide remains investigational and is not an FDA-approved medicine. It must not be marketed or represented as approved for weight loss, diabetes treatment or any other medical purpose.
For laboratory research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease.
- Product Name:
- Retatrutide
- Research Use:
- For Research Use Only
Benefits & Features
Purity Information
Display verified purity details entered for this product.
Batch Documentation
Show batch-specific product and certificate information.
Research Handling
Provide clear storage and laboratory handling guidance.
COA Access
Make the uploaded certificate of analysis easy to review.
Product Traceability
Use SKU, CAS and batch information for accurate identification.
Research Use Only
Clearly communicate the intended laboratory research use.
Third-Party Lab Report
Certificate of Analysis
View the product-specific Certificate of Analysis and transparent batch documentation supplied for this research product.
Trusted by Researchers
Real Feedback.
Real Results.
No approved product reviews are available yet. Real WooCommerce reviews will automatically appear here.
Elevate Your Research.
Premium peptides. Proven purity. Trusted worldwide.